Live Breaking News & Updates on Graft Vs Host Disease

Stay updated with breaking news from Graft vs host disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Supportive Care and Medication Access in GvHD

Hana Safah, MD, and Corey Cutler, MD, MPH, conclude with clinical insights on addressing medication access and the supportive care needs of patients with GvHD. ....

Hana Safah , Corey Cutler , New Treatment Options , Optimizing Care , Graft Vs Host Disease , Medication Access , Supportive Care , Gvhd Treatment ,

First-Line Therapy for Chronic GvHD

Hematologist-oncologists discuss the first-line treatment options for patients with chronic GvHD and the advantages and disadvantages of steroids. ....

New Treatment Options , Optimizing Care , Graft Vs Host Disease , Online Therapy , Chronic Gvhd , Chronic Graft Vs Host Disease , Steroid Toxicity ,

MaaT Pharma Announces Long Term Follow-Up Data for MaaT013 in Early Access Program to be Presented at the Upcoming EBMT Conference

LYON, France, March 12, 2024 Regulatory News: MaaT Pharma (EURONEXT: MAAT – the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer, will present extended results from its Early Access Program for patients with aGvHD that were treated with MaaT013 and, for the first time, Overall Survival data after 12 months in more patients. The data will be shared during an oral p ....

United States , Glasgow City , United Kingdom , Alexander Schauwvlieghe , Michael Loschi , Early Access Program , Corporate Communications , American Society Of Hematology , Meeting Of The European Society For Blood , Trophic Communications , Senior Pr Corporate Communications , Graft Vs Host Disease , Maat Pharma , Regulatory News , Microbiome Ecosystem , Overall Survival , Annual Meeting , European Society , Marrow Transplantation , Overall Response Rate , Nice Hospital , Oral Presentation , Microbiome Ecosystem Therapies , Euronext Paris , Investor Relations , Media Relations ,

Review Highlights Role of JAK Inhibition in Advancement of GVHD Prevention, Treatment

A group of researchers has compiled the latest advancements in preventing and treating graft-vs-host disease (GVHD).
....

Image Credit , Graft Vs Host Disease , Itacitinib ,

Overview of Graft-vs-Host Disease (GvHD)

Experts on graft-vs-host disease (GvHD) introduce themselves and provide an overview of GvHD, highlighting diagnosis, symptoms, risk stratification, and prevention. ....

New Treatment Options , Optimizing Care , Graft Vs Host Disease ,